Acucela Inc - Company & Market Research Reports

Acucela Inc., a Kubota Pharmaceutical Group company, is committed to translating innovation into a diverse portfolio of drugs and devices to treat blinding eye diseases that affect tens of millions of people worldwide. The company's orally-delivered VCM therapies, which selectively target cells within the retina to protect visual acuity, have the potential to be used to treat several devastating eye diseases, including dry age-related macular degeneration (AMD). Acucela was founded by Dr. Ryo Kubota in 2002.


Presbyopia Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations and Other Developments - Product Thumbnail Image

Presbyopia Therapeutics - Pipeline Analysis 2018, Clinical Trials & Results, Patents, Designations, Collaborations and Other Developments

  • Report
  • 77 Pages
From
Age-Related Macular Degeneration Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments - Product Thumbnail Image

Age-Related Macular Degeneration Therapeutics Pipeline Analysis, 2017 - Clinical Trials & Results, Patent, Designation, Collaboration, and Other Developments

  • Report
  • 143 Pages
From
Ophthalmology Drug Development Pipeline Review, 2016 - Product Thumbnail Image

Ophthalmology Drug Development Pipeline Review, 2016

  • Report
  • 633 Pages
From
Diabetic Macular Edema - Pipeline Review, H1 2018 - Product Thumbnail Image

Diabetic Macular Edema - Pipeline Review, H1 2018

  • Report
  • 209 Pages
From
Diabetic Macular Edema - Pipeline Review, H2 2017 - Product Thumbnail Image

Diabetic Macular Edema - Pipeline Review, H2 2017

  • Report
  • 193 Pages
From
Back of the Eye Disorders: Novel Drugs and Delivery Technologies, 2017-2030 - Product Thumbnail Image

Back of the Eye Disorders: Novel Drugs and Delivery Technologies, 2017-2030

  • Report
  • 292 Pages
From
Diabetic Retinopathy - Competitive Landscape, Pipeline and Market Analysis, 2017 - Product Thumbnail Image

Diabetic Retinopathy - Competitive Landscape, Pipeline and Market Analysis, 2017

  • Report
  • 100 Pages
From
Diabetic Retinopathy - Pipeline Review, H1 2018 - Product Thumbnail Image

Diabetic Retinopathy - Pipeline Review, H1 2018

  • Report
  • 219 Pages
From
Proliferative Diabetic Retinopathy (PDR) - Pipeline Review, H1 2018 - Product Thumbnail Image

Proliferative Diabetic Retinopathy (PDR) - Pipeline Review, H1 2018

  • Report
  • 52 Pages
From
Global Ophthalmology Drugs and Devices Market Insights, Opportunity Analysis, Market Shares and Forecast 2017 - 2023 - Product Thumbnail Image

Global Ophthalmology Drugs and Devices Market Insights, Opportunity Analysis, Market Shares and Forecast 2017 - 2023

  • Report
  • 140 Pages
From
Global Age-Related Macular Degeneration (AMD) Market Size, Share, Development, Growth and Demand Forecast to 2022 - Industry Insights by Type (Dry AMD, and Wet AMD), by Drug (Lucentis, Eylea, Visudyne, Avastin and Others) - Product Thumbnail Image

Global Age-Related Macular Degeneration (AMD) Market Size, Share, Development, Growth and Demand Forecast to 2022 - Industry Insights by Type (Dry AMD, and Wet AMD), by Drug (Lucentis, Eylea, Visudyne, Avastin and Others)

  • Report
From
North America Ophthalmic Devices & Drugs Market Growth, Trends and Forecasts 2017 - 2022 - Product Thumbnail Image

North America Ophthalmic Devices & Drugs Market Growth, Trends and Forecasts 2017 - 2022

  • Report
  • 126 Pages
From
Global Ophthalmic Drugs Market Growth, Trends and Forecasts 2017 - 2022 - Product Thumbnail Image

Global Ophthalmic Drugs Market Growth, Trends and Forecasts 2017 - 2022

  • Report
  • 198 Pages
From
Global Ophthalmic Drugs & Devices Market Growth, Trends and Forecasts 2017 - 2022 - Product Thumbnail Image

Global Ophthalmic Drugs & Devices Market Growth, Trends and Forecasts 2017 - 2022

  • Report
  • 198 Pages
From
Ocular Disorders: Rising Therapeutics, Technologies, and Devices - Overview  - Product Thumbnail Image

Ocular Disorders: Rising Therapeutics, Technologies, and Devices - Overview

  • Report
  • 208 Pages
From
Retinal Vein Occlusion - Pipeline Review, H1 2018 - Product Thumbnail Image

Retinal Vein Occlusion - Pipeline Review, H1 2018

  • Report
  • 106 Pages
From
Presbyopia - Pipeline Review, H1 2018 - Product Thumbnail Image

Presbyopia - Pipeline Review, H1 2018

  • Report
  • 35 Pages
From
Retinitis Pigmentosa (Retinitis) - Pipeline Review, H1 2018 - Product Thumbnail Image

Retinitis Pigmentosa (Retinitis) - Pipeline Review, H1 2018

  • Report
  • 188 Pages
From
Cataract - Pipeline Review, H1 2018 - Product Thumbnail Image

Cataract - Pipeline Review, H1 2018

  • Report
  • 45 Pages
From
Wet AMD- Pipeline Insight, 2018 - Product Thumbnail Image

Wet AMD- Pipeline Insight, 2018

  • Drug Pipelines
  • 106 Pages
From
Loading Indicator
adroll